Derivatives of imidazotriazine and pyrrolotriazine C-nucleosides as potential new anti-HCV agents.

Previous investigations identified 2'-C-Me-branched ribo-C-nucleoside adenosine analogues, 1, which contains a pyrrolo[2,1-f][1,2,4]triazin-4-amine heterocyclic base, and 2, which contains an imidazo[2,1-f][1,2,4]triazin-4-amine heterocyclic base as two compounds with promising anti-HCV in vitro activity. This Letter describes the synthesis and evaluation of a series of novel analogues of these compounds substituted at the 2-, 7-, and 8-positions of the heterocyclic bases. A number of active new HCV inhibitors were identified but most compounds also demonstrated unacceptable cytotoxicity. However, the 7-fluoro analogue of 1 displayed good potency with a promising cytotherapeutic margin.

Discovery and Synthesis of C-Nucleosides as Potential New Anti-HCV Agents.

Nucleoside analogues have long been recognized as prospects for the discovery of direct acting antivirals (DAAs) to treat hepatitis C virus because they have generally exhibited cross-genotype activity and a high barrier to resistance. C-Nucleosides have the potential for improved metabolism and pharmacokinetic properties over their N-nucleoside counterparts due to the presence of a strong carbon-carbon glycosidic bond and a non-natural heterocyclic base. Three 2'CMe-C-adenosine analogues and two 2'CMe-guanosine analogues were synthesized and evaluated for their anti-HCV efficacy. The nucleotide triphosphates of four of these analogues were found to inhibit the NS5B polymerase, and adenosine analogue 1 was discovered to have excellent pharmacokinetic properties demonstrating the potential of this drug class.

Antiviral agents 3. Discovery of a novel small molecule non-nucleoside inhibitor of hepatitis B virus (HBV).

The discovery of a small molecule non-nucleoside inhibitor of Hepatitis B Virus is described. During our work on conocurvone derived naphthoquinone 'trimers' for the treatment of HIV, we discovered a potent inhibitor 9 of Hepatitis B Virus in an antiviral screen. During attempts to resynthesis 9 for proof of concept studies, we altered the synthesis in order to attempt to reduced side reactions and difficult to remove by-products. As a result we discovered a small molecule 19 that also was a potent inhibitor of HBV. Importantly, this small molecule inhibitor of Hepatitis B Virus is also an inhibitor of Hepatitis B Virus resistant to 3TC, a bench mark of nucleoside analogues active in the treatment of Hepatitis B Virus. The development of 19 as an agent to treat HBV infections is discussed.

Translational isomerism and dynamics in multi-hydroquinone derived porphyrin [2]- and [3]-catenanes.

A series of porphyrins strapped with polyether chains containing two or three 1,4-dioxybenzene units has been synthesised with a view to the production of porphyrin-containing [2] and [3]catenanes, where the porphyrin is strapped between ortho-positions of 5,15-(meso)-diaryl groups, and is interlinked with the bipyridinium macrocycle cyclobis(paraquat-4,4'-biphenylene). The porphyrins were isolated as mixtures of atropisomers, where the linking strap spans across the face of the porphyrin (alpha,alpha-isomer), or 'twisted' around its side (alpha,beta-isomer). Their structures were determined by detailed 1H NMR spectroscopy. The bis-1,4-dioxybenzene-strapped derivatives were shown to undergo atropisomerisation on heating, to produce an equilibrium mixture. Catenation under high pressure conditions of the mixture, or of the individual isomers, produced only a single catenane, that of the alpha,alpha-isomer. Its structure was determined by mass spectral and dynamic NMR measurements. Rates were determined for: (i) translational motion or 'shuttling' between 1,4-dioxybenzenes; (ii) 'rotation' of the macrocycle around the 1,4-dioxybenzene axis; and (iii) 'rocking' of the 1,4-dioxybenzene within the macrocycle. The atropisomers of the strapped derivatives containing three 1,4-dioxybenzene units were also separated, and subjected to catenation. Both [2]- and [3]catenanes were isolated, and were shown to be stable to further atropisomerisation. Their solution structures were probed in detail by dynamic 1H NMR measurements. The rates for shuttling and rotation were obtained in certain cases, although the complexity of the spectra of the [3]catenanes prevented a more detailed investigation.

Photoinduced electron transfer between the interlocked components of porphyrin catenanes: effect of the presence of nonequivalent reduction sites on the charge recombination rate.

[2]Catenanes made up of several polyether-strapped porphyrin macrocycles interlinked with the cyclic electron acceptor cyclobis(paraquat-p-phenylene) were spectroscopically, photophysically, and electrochemically characterized. The catenanes exhibit very rich redox behavior due to the presence of several different and interacting electro-active subunits. The redox patterns represent useful "fingerprints" that provide detailed information on the electronic interactions and the chemical environments that the electroactive subunits experience in the supramolecular arrays. A photoinduced electron transfer from the porphyrin excited state (charge separation CS) occurs with tau=20 ps in the catenanes with a larger strap and faster than 20 ps (instrumental resolution) in the catenanes with a shorter strap. The resulting charge-separated state recombines to the ground state (charge recombination CR) with lifetimes similar in all cases, 41+/-4 ps. Comparison of the electron transfer rates CS and CR in the host-guest complexes of the same porphyrins with the noncyclic electron acceptor paraquat, indicate slower reactions in the [2]catenanes. This behavior is assigned to the different separation between reacting partners determined by the type of bond (weak interaction or mechanical) and to a two-step consecutive electron transfer to different sites of the macrocyclic electron acceptor in the catenanes which retards charge recombination.